Home | Survey | Payment| Talks & Presentations | Job Opportunities
Journals   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Chinese Journal of Cancer
1000-467X
2011 Issue 6
Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer
Juan Wei;Wen Gao;Cheng-Jun Zhu;Yi-Qian Liu;Zhu Mei;Ting Cheng and Yong-Qian Shu Department of Oncology;The First Affiliated Hospital;Nanjing Medical University;Nanjing;Jiangsu 210029;P.R.China.
..............page:407-414
Enrichment of osteosarcoma stem cells by chemotherapy
Qing-Lian Tang1;2;3;Yi Liang2;3;Xian-Biao Xie1;Jun-Qiang Yin1;Chang-Ye Zou1;Zhi-Qiang Zhao1;2;Jing-Nan Shen1 and Jin Wang1 1 Department of Musculoskeletal Oncology;FirstAffiliated Hospital;Sun Yat-sen University;Guangzhou;Guangdong510080;P.R.China;State Key Laboratory of Oncology in South China;2Guangzhou;Guangdong 510060;P.R.China;Research Department;3Sun Yat-sen University Cancer Center;Guangzhou;Guangdong 510060;P.R.China.
..............page:426-432
MicroRNA therapeutics:principles,expectations,and challenges
Rajesha Rupaimoole1;4;Hee-Dong Han1;4;Gabriel Lopez-Berestein2;3;4 and Anil K.Sood1;3;4 Department of 1Gynecologic Oncology;2Experimental Therapeutics;and 3Department of Cancer Biology;4Center for RNA Interference and Non-Coding RNA;The University of Texas M.D.Anderson Cancer Center;Houston;Texas 77030;USA.
..............page:368-370
Apoptosis and the target genes of microRNA-21
Lindsey E.Becker Buscaglia and Yong Li Department of Biochemistry and Molecular Biology;School of Medicine;University of Louisville;319 Abraham Flexner Way;Louisville;KY 40202;USA.
..............page:371-380
Information for Authors
..............page:433
Research progresses in the pathogenesis of anaplastic largecell lymphoma
Xiao-Lan Shi;Xiao-Wen Tang and De-Pei Wu Department of Hematology;the First Affiliated Hospitalof Soochow University;Jiangsu Institute of Hematology;Key Laboratoryof Thrombosis and Hemostasis of Ministry of Health;Suzhou;Jiangsu215006;P.R.China
..............page:392-399
Single-nucleotide polymorphisms among microRNA:big effects on cancer
Feng-Ju Song1;2 and Ke-Xin Chen1;2 Department of Epidemiology and Biostatistics;1Tianjin Medical University Cancer Hospital and Institute;Tianjin 300060;P.R.China;Key Laboratory of Breast Cancer Prevention and Therapy;2Tianjin Medical University;Ministry of Education;Tianjin 300060;P.R.China
..............page:381-391
About the Cover
..............page:356
RNA interference of pax2 inhibits growth of transplanted human endometrial cancer cells in nude mice
Li-Ping Zhang1;Xiao-Yan Shi2;Chang-Yin Zhao1;Yong-Zhen Liu1 and Ping Cheng1 Department of Gynecology and Obstetrics;Taihe 1Hospital;Hubei Medical University;Shiyan;Hubei 442000;P.R.China;2Central Laboratory;Central Hospital of Wuhan;Tongji Medical College;Huazhong University of Science and Technology;Wuhan;Hubei 430014;P.R.China.
..............page:400-406
Loss of A-type lamin expression compromises nuclear envelope integrity in breast cancer
Callinice D.Capo-chichi1;2;Kathy Q.Cai3;Jennifer Smedberg3;Parvin Ganjei-Azar1;4;Andrew K.Godwin5 and Xiang-Xi Xu1;2;6 1Sylvester Comprehensive Cancer Center;2Department of Medicine;4Department of Pathology;and 6Department of Obstetrics and Gynecology;University of Miami School of Medicine;Miami;FL 33136;USA;3Ovarian Cancer Program;Fox Chase Cancer Center;Philadelphia;PA 19111;USA;5Department of Pathology and Laboratory Medicine;University of Kansas Medical Center;Kansas City;KS 66160;USA.
..............page:415-425
Outstanding young Chinese scholars making an impact in the US and China:a joint award program of the US Chinese Anti-Cancer Association and the US National Foundation for Cancer Research
Shi-Yuan Cheng1;2;Li Yan2 and Wei Zhang2;3 1Department of Pathology; University of Pittsburgh Cancer Institute; Pittsburgh;PA 15232-1301;USA;2US Chinese Anti-Cancer Association;Los Angeles; CA 90034-6364;USA;3Department of Pathology; University of Texas M.D.Anderson Cancer Center;Houston;TX 77030;USA.
..............page:357-362
A proposal:a comprehensive platform to characterize tumors in Chinese and improve success in cancer drug discovery and development
Pearl S.Huang1;Peter T.Ho1 and Kang Zhang2;3 1Beigene Ltd.;Beijing 102206;P.R.China;2Molecular Medicine Center;West China Hospital;Sichuan University;Chengdu;Sichuan 610041;P.R.China;3Institute for Genomic Medicine and Shiley Eye Center;University of California at San Diego;La Jolla;CA 92093;USA.
..............page:363-367